����app

Chair of the Scientific Advisory Board

Prof Chas Bountra OBE

Chas is Pro-Vice Chancellor for Innovation at the University of Oxford, Professor of Translational Medicine in the Nuffield Department of Clinical Medicine, Director of the Centre for Medicines Discovery, and Professorial Fellow at Keble College, Oxford. Prior to returning to Oxford in 2008, Chas was Vice President and Head of Biology at GlaxoSmithKline.

Chas is an invited expert on several government and charitable research funding bodies, and an advisor for many academic, biotech and pharma drug discovery programmes. In 2012 he was voted one of the “top innovators in the industry”, in 2014 received the “Rita and John Cornforth Award” from the Royal Society of Chemistry, in 2017 and 2018 was voted “Master of the Bench” from the Medicine Maker Power List, and in 2018 was awarded the “Order of the British Empire” in the New Years Honours List.

Scientific Advisory Board MembEr

Prof Rury Holman MB, ChB. FRCP(Lon). FMedSci

Rury is a globally recognized authority on diabetes and cardiometabolic diseases. He is an Emeritus Professor of Diabetic Medicine at the University of Oxford and former Director of the University of Oxford Diabetes Trials Unit, where he has led groundbreaking clinical research in diabetes management and cardiometabolic diseases.

His accolades, including the ADA Harold Rifkin Award for Distinguished International Service, the Diabetes UK Robert Turner Award for Research Impact and the 2024 ADA Banting Medal for Scientific Achievement, underscore his significant contributions to the field. Rury’s scientific insight will be instrumental as ����app pioneers new approaches targeting mitochondria in obesity, aiming to develop innovative therapies that address the underlying mechanisms of metabolic disease.

Scientific Advisory Board Member

Dr. Milos Filipovic

Dr. Milos Filipovic is a distinguished researcher with expertise in chemical biology who brings his wealth of experience in cysteine post-translational modifications and their implications in aging and aging-associated diseases. Having led research groups at prestigious institutions such as the French National Centre for Scientific Research (CNRS) and the Leibniz Institute for Analytical Sciences in Dortmund, Dr. Filipovic's insights will be invaluable in advancing ����app's understanding of redox changes in cellular signaling.

Scientific Advisory Board Member

Prof Ele Ferrannini, MD

ADA Banting Prize Winning KOL associated with the University of Pisa as well as Yale and the Texas Health Science Centre.  Renowned for his contributions to the fields of phenotyping insulin resistance and association disorders, beta-cell function and dysfunction, the incretin effect and cardiovascular complications of diabetes. Pioneering contributions in DPP-4 and SGLT2 inhibition.